A review on ANDA submission requirements for Generic drugs: “Paragraph IV certification” as per FDA CDER guidelines
Journal Title: International Journal of Drug Regulatory Affairs - Year 2018, Vol 6, Issue 3
Abstract
USFDA is one the most regulated agencies wherein the submission process is most critical. The study depends on how to submit ANDA application as per FDA, CDER guidelines in paragraph IV submission in Federal Food, Drug, and Cosmetic Act (FD&C Act). No drug would be available in the market until and unless it get approved by Regulatory Authorities. “Paragraph IV Certification” is useful for exclusive right to market the generic drug for 180 days. Submission is for the company which is seeking to copy branded drug before expiration of patents to get benefit over it, a generic applicant must provide in its application a "certification" that a patent submitted to FDA by the brand-name drug's sponsor and listed in FDA's Approved Drug Products with Therapeutic Equivalence Evaluations (the Orange Book). A Generic Product must meet the standards established by FDA in RLD (Reference listed drug). This study covers the introduction of ANDA submission to FDA and ACT related to the submission in to paragraph IV and the details of ANDA filling in the eCTD format and overview of review process the checklist to the applicant.
Authors and Affiliations
Saffiya khatun M, Jyothshna Devi Katamreddy, Jayachandra Reddy. P
Keywords
Related Articles
- EP ID EP426882
- DOI 10.22270/ijdra.v6i3.260
- Views 80
- Downloads 0
A review on ANDA submission requirements for Generic drugs: “Paragraph IV certification” as per FDA CDER guidelines
USFDA is one the most regulated agencies wherein the submission process is most critical. The study depends on how to submit ANDA application as per FDA, CDER guidelines in paragraph IV submission in Federal Food, Drug,...
Pre-filled syringes in developed and developing region: An insight into Regulatory considerations
A Pre-filled syringe is a disposable syringe that is supplied already loaded with the substance to be injected. It is a unit dose of parenteral medication to which a needle has been fixed by a producer. They are small wh...
OVERVIEW OF DRUG REGULATORY AFFAIRS AND REGULATORY PROFESSION
Pharmaceutical drug regulatory affairs govern registration parameters of pharmaceutical products. It has a broad spectrum covering all aspects of documentation and marketing in legalized form. The pharmaceutical industry...
NUTRACEUTICALS - A REGULATORY REVIEW
The Nutraceuticals are the emerging sector in the Pharma Industry. As people are more and more concerned about their health and diseases caused by the malnutrition, the growth of the Nutraceuticals worldwide are inevitab...
OCULAR DRUG DELIVERY: RECENT UPDATES
Ophthalmic route is one of the most promising delivery systems for the treatment of eye ailments. Delivery of medicaments to anterior segment of the eye is an easy task. However with the rising number of posterior segmen...